Skip to Content Facebook Feature Image

Sharp HealthCare Chooses Abridge for Clinical Documentation, Enabling Clinicians to Focus on Care—Not Coding

News

Sharp HealthCare Chooses Abridge for Clinical Documentation, Enabling Clinicians to Focus on Care—Not Coding
News

News

Sharp HealthCare Chooses Abridge for Clinical Documentation, Enabling Clinicians to Focus on Care—Not Coding

2025-04-10 20:30 Last Updated At:20:41

SAN DIEGO & SAN FRANCISCO--(BUSINESS WIRE)--Apr 10, 2025--

Sharp HealthCare, the largest integrated health system in San Diego, is implementing the Abridge generative AI platform across the enterprise to create comprehensive, compliant, and billable documentation, enabling clinicians to fully focus on caring for patients. Abridge will now be deployed across Sharp HealthCare locations, which support more than one million patients annually.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250410805726/en/

Medical records serve many purposes and stakeholders. They are the health record for patients, a guide for other clinicians on the care team, and a part of how clinicians receive compensation for the care provided.

“If you didn't write it down, it didn't happen,” said Dr. Brian Lichtenstein, a hospitalist and Associate Chief Medical Information Officer (CMIO) of Acute Care at Sharp HealthCare. “With Abridge, we’re picking up on additional conditions our clinicians are treating that might have otherwise been lost. Even when you're trying to be exhaustive in your notes, you may document eight of ten things that you did, which is good, but getting all ten is great and helps us realize more of the value of what we deliver.”

Abridge’s capability to support clinicians and health systems in capturing all of the value they deliver is enabled by the platform’s Contextual Reasoning Engine, an AI architecture that generates compliant, structured, and billable notes, in real-time, at the point of care.

“A colleague told me that Abridge more completely captures all the work he is doing,” said Dr. Elan Hekier, Pulmonary and Critical Care Medicine Physician and CMIO of Sharp Rees-Stealy Medical Group, a Sharp HealthCare physician practice. “It even captured a diagnosis he says he would have missed. It was during the exam and he had forgotten about it by the end of the long visit. But Abridge appropriately added that diagnosis.”

Following a pilot in which Abridge was rigorously tested across specialties, languages, and care settings, Sharp HealthCare clinicians experienced:

This data was collected using a pre-post survey and included a self-reported 10% increase in clinicians’ ability to see additional patients that needed urgent attention.

“I’m Spanish-speaking, and sometimes I speak in Spanglish with my patients. Abridge’s HPI and A&P always pick up way more than I used to catch, regardless of the language,” said Dr. Nicole Tremain, an internal medicine clinician as well as Associate CMIO at the Sharp Community Medical Group, another Sharp HealthCare physician practice.

Abridge is now trusted by more than 100 of the largest and most complex health systems to deliver highly accurate clinical documentation relied upon by clinicians, patients, and revenue cycle professionals every day.

“Enterprise-grade healthcare AI removes barriers between patients and clinicians and delivers ROI for healthcare systems,” said Dr. Shiv Rao, CEO and Founder of Abridge. “The clinicians and AI scientists who designed Abridge understand the anxiety creating compliant, billable documentation can cause among clinicians—our mission is to relieve that burden so they can focus on delivering exceptional patient care.”

About Sharp HealthCare
Sharp HealthCare, San Diego's largest and most comprehensive health care delivery system, is recognized for clinical excellence in cardiac, cancer, multi-organ transplantation, neuroscience, orthopedics, rehabilitation, behavioral health, women's health and hospice services. Sharp HealthCare has been widely acclaimed for its commitment to transform the health care experience for patients, physicians and staff through an organization-wide performance improvement initiative called The Sharp Experience. The Sharp HealthCare system includes four acute-care hospitals, four specialty hospitals, three affiliated medical groups, a health plan and numerous outpatient facilities and programs, including the Sharp Prebys Innovation & Education Center. To learn more about Sharp, visit Sharp Health News.

About Abridge
Abridge was founded in 2018 to power deeper understanding in healthcare. The enterprise-grade AI platform transforms medical conversations into clinically useful and billable documentation at the point of care, reducing administrative burden and clinician burnout while improving patient experience. With deep EHR integration, support for 28+ languages, and 50+ specialties, Abridge is used across a wide range of care settings, including outpatient, emergency department, and inpatient.

Abridge’s enterprise-grade AI platform is purpose-built for healthcare. Supported by Linked Evidence, Abridge is the only solution that maps AI-generated summaries to source data, helping clinicians quickly trust and verify the output. As a pioneer in generative AI for healthcare, Abridge is setting the industry standard for the responsible deployment of AI across health systems.

Abridge was recently awarded Best in KLAS for Ambient AI segment in addition to other accolades, including TIME Best Inventions of 2024, 2024 Forbes AI 50 List, and Fortune’s 2024 AI 50 Innovators.

Sharp HealthCare Chooses Abridge for Clinical Documentation, Enabling Clinicians to Focus on Care—Not Coding

Sharp HealthCare Chooses Abridge for Clinical Documentation, Enabling Clinicians to Focus on Care—Not Coding

Sharp HealthCare Chooses Abridge for Clinical Documentation, Enabling Clinicians to Focus on Care—Not Coding

Sharp HealthCare Chooses Abridge for Clinical Documentation, Enabling Clinicians to Focus on Care—Not Coding

LONDON (AP) — King Charles III has been “deeply touched” by the response to his update on his cancer treatment, Buckingham Palace said Saturday, adding that the monarch is pleased to have highlighted the value of screening programs for the disease.

Medics and health charities have praised the king for his openness, saying his statement on Friday had already prompted people to seek information about cancer.

In a strikingly personal video statement, the British monarch acknowledged that a cancer diagnosis can feel “overwhelming,” but said catching the disease early brings “the precious gift of hope.”

Here’s what to know about the king's condition and his message.

The 77-year-old king said in a statement broadcast Friday that his treatment schedule will be reduced in the new year, “thanks to early diagnosis, effective intervention and adherence to ‘doctors’ orders.’”

He encouraged others to take advantage of screening programs such as those for breast, bowel and cervical cancer offered by Britain’s public health service.

“Early diagnosis quite simply saves lives,” the king said in the statement aired during a “Stand Up to Cancer” telethon on TV station Channel 4. He said catching the disease early had allowed him “to continue leading a full and active life even while undergoing treatment.”

Charles has received outpatient treatment for almost two years. Buckingham Palace did not say the king is in remission, but that his treatment is moving to a “precautionary phase” and his condition will be monitored to ensure his continued recovery.

“I know from my own experience that a cancer diagnosis can feel overwhelming,” the king said in his video statement. “Yet I also know that early detection is the key that can transform treatment journeys, giving invaluable time to medical teams – and, to their patients, the precious gift of hope.”

Charles announced in February 2024 that he had been diagnosed with cancer, and, in a break from centuries of secrecy about royal health, he has since spoken about the illness, using his story to promote cancer awareness and treatment.

The openness has limits, though. The king has not disclosed what type of cancer he has or what kind of treatment he is receiving. The palace said it was an intentional decision designed to ensure his message reaches the widest possible audience.

The king’s cancer was discovered after treatment for an enlarged prostate. While doctors ruled out prostate cancer, tests revealed “a separate issue of concern,” palace officials said last year.

Charles suspended his public appearances for about two months after his diagnosis. Since returning to the public eye, he has visited cancer treatment centers across the country and shared stories with fellow patients.

Buckingham Palace said Charles “will be greatly encouraged and deeply touched by the very positive reaction" his message has generated. “He will be particularly pleased at the way it has helped to shine a light on the benefits of cancer screening programs,” it added.

British cancer charities said the number of people seeking information about cancer jumped after the king revealed he was undergoing treatment last year.

Cancer Research U.K. said about 100,000 people have visited its Screening Checker website since it was launched on Dec. 5, most of them since the king’s statement on Friday.

The charity's Chief Executive Michelle Mitchell said: “When public figures speak openly about their cancer diagnosis, it can prompt others to check in on their health.”

Broadcaster Jonathan Dimbleby, the king’s authorized biographer, said the statement was “a remarkable thing for a monarch to do.”

“It takes guts, and the fact that he came out and did that will save lives,’” Dimbleby said.

The Princess of Wales, who announced her own cancer diagnosis six weeks after her father-in-law, has also given updates on her treatment. Kate announced in January that her cancer is in remission.

Find more of AP’s coverage at https://apnews.com/hub/royalty

Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)

Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)

Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)

Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)

Recommended Articles